logo
Looming de minimis restrictions put importers at a crossroads

Looming de minimis restrictions put importers at a crossroads

Yahoo28-02-2025

This story was originally published on Supply Chain Dive. To receive daily news and insights, subscribe to our free daily Supply Chain Dive newsletter.
Without de minimis treatment for imports from key U.S. trading partners, companies are now figuring out the best path forward for their supply chains.
During a webinar last week, cross-border logistics experts said there are several paths businesses can take depending on their particular needs. However, a deluge of trade policy changes and uncertainty about future regulations are making those decisions harder.
"It's just fatigue around the conversation, because they just want to know what the rules are going to be," Maggie Barnett, CEO of LVK Logistics, said.
The de minimis exemption is often leveraged by cross-border e-commerce shippers to ship sub-$800 products into the U.S. without having to pay additional duties, limiting shipping costs in the process.
The Trump administration plans to ax the exemption for products from China permanently once "adequate systems are in place' to quickly process and collect related tariff revenue. De minimis eligibility is also slated to be cut for goods from Canada and Mexico under executive orders slated to take effect next week.
Using a U.S.-based 3PL is a strong option at the current juncture, according to Barnett, since she expects the de minimis exemption will receive further scrutiny even when it no longer applies to shipments from China. If a company aggressively shifts their sourcing to Bangladesh, Vietnam or another country, that could just leave them vulnerable to future U.S. trade actions, Barnett said.
"Why would they just close this for China?" Barnett said, referring to de minimis treatment. "If the mandate is to reduce fentanyl, increase revenues into the U.S. and increase U.S. jobs, why just stop at China?"
Companies need to find a long-term fulfillment solution with less exposure to rapidly changing trade policies, as frequent supply chain shifts can be expensive for brands, Barnett added. Companies with 20,000 to 25,000 SKUs could incur expenses up to $100,000 just to move their inventory to a new 3PL, she said.
"That's where the idea of coming back to a U.S. 3PL is basically the best option at this point," Barnett said.
Aaron Rubin, CEO of warehouse management system provider ShipHero, recommended smaller brands lean on U.S.-centric operations and domestic 3PLs, while advising larger brands to partner with a capable customs broker and lawyer to minimize tariff costs.
Higher brokerage fees are also a concern as importers navigate new trade rules. In response, Rubin said some companies are trying to clear as many products as possible in one customs entry, grouping them by both the client they're serving and the applicable Harmonized System (HS) code.
"If you can do a formal entry and every line is going to be separate, you're going to run into a lot of brokerage fees," Rubin said. "And most people are using this to save, like, a couple dollars per package."
Companies should weigh labor costs as well in determining their de minimis response. Mexico is a key location for fulfillment into the U.S., and eliminating the exemption won't entirely erase that, according to Rubin. That's because brands can still leverage Mexico's lower labor costs for more hands-on processes. This includes fulfilling shipments that are kitted — combining multiple items into a single package — or have more complex manufacturing needs.
Experts also floated the use of Type 11 entry as an alternative for de minimis-reliant importers, although that requires more information during the customs process.
Type 11 entry is a simplified procedure where goods can be cleared through customs without a bond as long as the shipment's value doesn't exceed $2,500, or $250 for China-based goods covered by Section 301 tariffs, Portless CEO Izzy Rosenzweig said in a LinkedIn post. Portless has been testing Entry Type 11 "with great results," according to Rosenzweig.
Importers may adjust more quickly to Type 11 entries in the future after using the process during the initial ban on de minimis shipping from China earlier this month, said Scott Sangster, general manager of global logistics service providers at Descartes Systems Group, in an interview with Supply Chain Dive. Companies are "getting better at comparing the information that they're going to need to continue to comply with different types of filings," he added.
"The Type 11 informal entry was the most natural entry for people to move to," Sangster said.
Editor's note: This story was first published in our Logistics Weekly newsletter. Sign up here.
Recommended Reading
De minimis exemption temporarily returns for products from China

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UPS surcharge updates impact fuel fees, bulky packages and more
UPS surcharge updates impact fuel fees, bulky packages and more

Yahoo

time3 days ago

  • Yahoo

UPS surcharge updates impact fuel fees, bulky packages and more

This story was originally published on Supply Chain Dive. To receive daily news and insights, subscribe to our free daily Supply Chain Dive newsletter. UPS has rolled out a barrage of surcharge changes since May that could introduce further pricing pressure for shippers. The carrier has hiked its fuel fee calculations, added a new international levy and tweaked the list of ZIP codes in which delivery area surcharges apply, among other adjustments. Updates to how fees on bulky packages are calculated will take effect Aug. 17. "UPS rate updates help to support ongoing expansion and capability enhancements as we strive to maintain the high service levels you expect from UPS," the company said on its website. Surcharge What's changing Effective date International Fuel Surcharge Fuel surcharge calculations increased for ground and air imports and exports. May 12 Domestic Fuel Surcharge Fuel surcharge calculations increased for ground, air and Ground Saver packages. May 26 Delivery Area Surcharge List of ZIP codes the fee applies to changed. June 1 International Collect on Delivery Fee The new $12 fee is charged to the U.S. consignee, unless duties and taxes are billed to a UPS account or paid electronically prior to delivery. June 2 Additional Handling and Large Package Surcharges Higher fees for Zone 7 and above shipments began applying. June 2 Remote Area Surcharge Ground Saver deliveries now have this fee applied to ZIP codes deemed as remote areas in the contiguous U.S. June 2 Domestic Large Package Surcharge No longer calculated based on length plus girth. Instead, packages weighing over 110 pounds or with a size greater than 17,280 cubic inches will be subject to the fee. Aug. 17 Domestic Additional Handling Charge No longer calculated based on length plus girth. Instead, packages with a size greater than 8,640 cubic inches will be subject to the fee. Aug. 17 Source: UPS UPS and rival FedEx have accelerated the frequency of surcharge changes over the past few years in a bid to boost profitability, experts have told Supply Chain Dive. Although discounts offered by the delivery giants are softening the blow, the fee hikes are contributing to customers' higher shipping expenses. "You keep getting these changes forced into this network, and you haven't budgeted for it, along with all of the other stuff you're dealing with as a shipper, and it is difficult," said Adi Karamcheti, a senior consultant of professional services at Shipware. Fuel surcharges have been a particular thorn in shippers' side recently, with several increases levied since 2024. UPS increased its fuel surcharge calculations for domestic shipments by 100 basis points on May 26. The carrier adjusts the index-based fees weekly based on average diesel fuel and jet fuel prices. Those prices determine the surcharge rate UPS applies for deliveries. This means if the diesel fuel index's price per gallon is $3.20, a UPS Ground or Ground Saver delivery now incurs an 18.75% fee instead of a 17.75% markup under previous calculations. The move comes less than three months after UPS increased its domestic fuel surcharge calculations by 50 basis points. Beyond fuel prices, UPS customers need to keep up with upcoming changes to how large package and additional handling fees are calculated. Now those surcharges consider a package's cubic inch total rather than a combination of length and girth. Shippers with bulkier items, like patio furniture, aftermarket car parts or recreational equipment, should pay extra attention to how the new calculations will influence what charges apply and when, said Gene Pawlak, who is also a senior consultant of professional services at Shipware. Shippers have ways to blunt the impact of rate and fee hikes, according to a post on the website of Reveel, a parcel spend management provider. This includes focusing contract negotiations on the surcharges they are most heavily exposed to, minimizing empty space when packaging products and leveraging warehouses closest to end customers. Recommended Reading Parcel delivery rates: What 2025 could bring FedEx, UPS shippers Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?
REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?

Yahoo

time4 days ago

  • Yahoo

REGN Strengthens Obesity Pipeline: Will the Move Revive the Stock?

Regeneron Pharmaceuticals, Inc. REGN is looking to make inroads in the lucrative obesity market. The company recently entered into an in-licensing agreement for an obesity drug with Hansoh Pharmaceuticals Group Company Limited, in a bid to expand its clinical-stage obesity portfolio. The licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist. Regeneron will acquire exclusive clinical development and commercial rights for HS-20094, a dual GLP-1/GIP receptor agonist, outside the Chinese Mainland, Hong Kong and Macau. Per the terms of the agreement, Regeneron will make an upfront payment of $80 million to Hansoh, with potential additional payments of up to $1.93 billion for achievement of development, regulatory and sales milestones. Any royalties on global net sales in the future (outside the designated territories) would be in the low double digits. HS-20094 has been evaluated in over 1,000 patients and administered as a weekly subcutaneous injection. The candidate has demonstrated promising efficacy and safety clinical data, suggesting a potentially similar profile to the only FDA-approved GLP-1/GIP receptor agonist. The candidate is currently being evaluated in a phase III study in obesity in China, and a phase IIb study in diabetes is ongoing. The in-licensing agreement for an obesity candidate will expand REGN's obesity pipeline, which includes trevogrumab. Regeneron recently announced positive interim results from the ongoing phase II COURAGE study investigating novel combinations of semaglutide (GLP-1 receptor agonist) and trevogrumab (anti-GDF8/anti-myostatin) with or without garetosmab (anti-activin A) for the treatment of obesity. COURAGE was designed to investigate the quality of weight loss in patients with obesity. Results showed that approximately 35% of semaglutide-induced weight loss was due to loss of lean mass, and further demonstrated that combining semaglutide with trevogrumab with or without garetosmab helped preserve lean mass while increasing loss of fat mass. Garetosmab is being evaluated for the treatment of fibrodysplasia ossificans progressive. The successful development of any obesity treatment will be a great boost for the company. We note that REGN has had a rough time so far this year. The stock got hammered last week after REGN and partner Sanofi SNY reported results from two late-stage studies, AERIFY-1 and AERIFY-2, on itepekimab for the treatment of chronic obstructive pulmonary disease (COPD). While the AERIFY-1 study met the primary endpoint, AERIFY-2 did not meet the same. REGN and SNY are currently reviewing the data and plan to discuss the next steps with regulatory authorities. Year to date, REGN's shares have lost 31.7% compared with the industry's 3.2% decline. Image Source: Zacks Investment Research Regeneron's performance in the first quarter was dismal. The plunge in Eylea sales adversely impacted the top line. Eylea sales have been under pressure for some time now due to competition from Roche's Vabysmo. Regeneron Pharmaceuticals, Inc. price-consensus-eps-surprise-chart | Regeneron Pharmaceuticals, Inc. Quote Regeneron has a tough road ahead, as it will take a long time for Eylea HD to contribute significantly to the top line. Apart from Eylea, profits from the sales of asthma drug Dupixent are a primary growth driver for REGN. Regeneron has a collaboration agreement with Sanofi for Dupixent. While the obesity market is lucrative, REGN is a pretty late entrant here. The market is dominated by bigwigs like Novo Nordisk NVO and Eli Lilly LLY. The stupendous success of Novo Nordisk's obesity drug, Wegovy (semaglutide) and Eli Lilly's Zepbound has prompted many companies to join the bandwagon. Buoyed by this success, both Lilly and NVO have taken significant strides in developing their obesity portfolios further. Given the significant market potential of obesity, other players are also striving to grab a chunk of this pie. Regeneron currently has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report Sanofi (SNY) : Free Stock Analysis Report Novo Nordisk A/S (NVO) : Free Stock Analysis Report Eli Lilly and Company (LLY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

Why Navitas Semiconductor Rocketed 164% in May
Why Navitas Semiconductor Rocketed 164% in May

Yahoo

time4 days ago

  • Yahoo

Why Navitas Semiconductor Rocketed 164% in May

Navitas is a small-cap semiconductor stock with declining revenues and operating losses. However, the company was named as a partner for Nvidia's upcoming Kyber data center power infrastructure. Navitas took the opportunity of a higher stock price to raise cash via equity sales, bolstering its balance sheet. 10 stocks we like better than Navitas Semiconductor › Shares of Navitas Semiconductor (NASDAQ: NVTS) rocketed 164.2% in May, according to data from S&P Global Market Intelligence. Entering the month, Navitas has been a small designer of gallium nitride (GaN) and silicon carbide (SiC) chip designs. These niche chips had primarily targeted electric vehicles and electrified infrastructure. But given the recent downturns in these markets, Navitas had seen its revenue go into reverse and its bottom line continuing to lose money. But in mid-May, Nvidia named Navitas as a key partner for Nvidia's upcoming Kyber data center infrastructure, which will be a new architecture to support Rubin-based sever racks beginning in 2027. While other power chip providers were also named, the fact that Navitas was so small, at just $350 million or so market cap at the time of the announcement, caused a massive rally in the stock. Navitas then used the opportunity to sell stock and bolster its balance sheet, extending its runway, likely until the 2027 time frame. As Nvidia explained in a May 20 blog post, the current 54 V DC power distribution systems in today's data centers will push up against their physical limits as AI server racks go to needing 200 kilowatts to power next-generation AI chips. To counter this, Nvidia is developing a ground-up redesign of data centers to an 800 V HVDC power architecture. Nvidia also noted that it was collaborating with a number of power chip and infrastructure companies early on as it develops the new data center power infrastructure, which Nvidia plans to unveil in 2027 for its upcoming Rubin-based systems. The following day, Navitas published its own blog post explaining how the new 800 V architecture will use both Navitas' SiC chips in the power room of data centers, which convert AC grid power to DC power for the data center, and then GaN-based power converters at the server rack level. The day of the blogs, May 21, Navitas rocketed 150% higher, before retreating. But then the following week, Navitas disclosed it had exhausted its $50 million equity at-the-market sales facility, and that it had filed for a new $50 million facility. Normally, when a company notes it has and will dilute shareholders, the stock goes down. But since Navitas' stock had gone up so much, investors viewed the capital raise as a positive, in that it fortified Navitas' balance sheet to bridge more of the time gap between now and 2027. While the prospect of a small company partnering up with Nvidia is highly tantalizing, there weren't any financial terms disclosed in the announcements. That makes sense, as the platform isn't even fully developed yet, and revenues from the venture aren't likely to come before 2027. So it's hard to say right now if Navitas has moved too far, too fast. Still, last month's cash raise will bolster Navitas' balance sheet, giving it more time to build out its platform in anticipation of the 2027 Kyber rollout. Before you buy stock in Navitas Semiconductor, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Navitas Semiconductor wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Billy Duberstein and/or his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Why Navitas Semiconductor Rocketed 164% in May was originally published by The Motley Fool

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store